TowerBrook and CD&R Acquire R1 RCM for $8.9 Billion

August 1, 2024

Investment funds affiliated with TowerBrook Capital Partners and Clayton, Dubilier & Rice agreed to acquire all outstanding shares of R1 RCM Inc. in an all-cash transaction valuing the company at approximately $8.9 billion ($14.30 per share). The transaction will take R1 private to support continued investment in its revenue-cycle automation platform and expansion of intelligent automation and generative AI capabilities for healthcare providers.

Buyers
TowerBrook Capital Partners, Clayton, Dubilier & Rice (CD&R)
Targets
R1 RCM Inc.
Sellers
Public shareholders of R1 RCM
Location
Utah, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.